Search results
AMD STOPPER Offers New Hope to Sufferers of Age-Related Macular Degeneration | Healthcare Dive
Healthcare Dive· 15 hours agoFearful of losing all of his central vision to the gradual blinding effects of Age-Related Macular Degeneration (AMD), a California-based researcher with ...
Breakthrough Study Reveals Somavedic Device's Potential Impact on Wet AMD Patients
WTNH-TV New Haven· 7 hours agoHospital in Ústí nad Labem in the Czech Republic, have unveiled groundbreaking findings from a study showcasing the effectiveness of the Somavedic device in supporting individuals with wet age-related ...
Byooviz dosage: Form, strength, when to use, and more
Medical News Today· 5 days agoByooviz (ranibizumab-nuna) is a brand-name drug prescribed for certain eye conditions in adults. It...
Health Care Roundup: Market Talk
The Wall Street Journal· 1 day agoMoreover, its planned launch of aflibercept—for patients living with wet macular degeneration—could be a potentially significant biosimilar opportunity,...
Toppling Goliath Brewing Co. partners with BREWS for BLiNDNESS
The Hannibal Courier-Post· 5 days agoToppling Goliath Brewing Co. has partnered with Iowa based Non-Profit BREWS for BLiNDNESS to support...
Nanoscope Therapeutics to Present at the World Orphan Drug Congress 2024
WTVO - WQRF Rockford· 6 days ago...Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that Sulagna Bhattacharya, Chief Executive Officer and Samarendra...application of Nanoscope's...
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC...
Fontana Herald News· 23 hours agoPharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today that ...
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Morningstar· 5 days ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet ...
Saffron and sight: Study explores longer-term effects
Nutraingredients.com· 8 hours agoAccording to a recent study published in BMJ Open Ophthalmology, 12 months of saffron...
I Can See Clearly Now: Eye Care for Seniors Begins at 50 - The Baltimore Times
Baltimore Times· 4 days agoIf you can recall the Johnny Nash 70’s chart-topping hit “I Can See Clearly Now” or grew up watching...
